HER2 targeting antibody-drug conjugate (breast cancer)

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECIFIC BREAST CANCER
US 2024148894 A1Applicant: REMEGEN CO LTDPriority: 2021
CN
EP
US
WO
4 publications
USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-LOW EXPRESSING BREAST CANCER
US 2024207424 A1Applicant: REMEGEN CO LTDPriority: 2021
CN
EP
US
WO
4 publications
USE OF ADC TARGETING HER2 IN TREATMENT OF BREAST CANCER
WO 2025131036 A1Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTDPriority: 2023
CN
WO
2 publications
METHOD FOR TREATING CERVICAL CANCER, THYMIC TUMOR, OR HORMONE RECEPTOR-POSITIVE AND HER2-NEGATIVE BREAST CANCER
WO 2025190255 A1Applicant: BIO THERA SOLUTIONS LTDPriority: 2024
WO
BREAST CANCER TREATMENT
WO 2026112550 A1Applicant: CARDIFF ONCOLOGY INCPriority: 2024
WO